Callan Family Office LLC Purchases 39,152 Shares of GE HealthCare Technologies Inc. $GEHC

Callan Family Office LLC boosted its position in GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 229.6% in the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 56,207 shares of the company’s stock after purchasing an additional 39,152 shares during the period. Callan Family Office LLC’s holdings in GE HealthCare Technologies were worth $4,163,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors have also added to or reduced their stakes in GEHC. N.E.W. Advisory Services LLC bought a new stake in GE HealthCare Technologies in the first quarter worth about $25,000. Bogart Wealth LLC lifted its stake in GE HealthCare Technologies by 260.0% in the first quarter. Bogart Wealth LLC now owns 342 shares of the company’s stock worth $28,000 after purchasing an additional 247 shares during the last quarter. Stonebridge Financial Group LLC increased its position in shares of GE HealthCare Technologies by 165.7% during the first quarter. Stonebridge Financial Group LLC now owns 356 shares of the company’s stock worth $29,000 after acquiring an additional 222 shares during the period. Olde Wealth Management LLC purchased a new position in shares of GE HealthCare Technologies during the first quarter worth approximately $35,000. Finally, Game Plan Financial Advisors LLC increased its position in shares of GE HealthCare Technologies by 295.3% during the second quarter. Game Plan Financial Advisors LLC now owns 502 shares of the company’s stock worth $37,000 after acquiring an additional 375 shares during the period. Institutional investors own 82.06% of the company’s stock.

Analyst Upgrades and Downgrades

A number of equities analysts have recently commented on GEHC shares. Weiss Ratings reaffirmed a “hold (c)” rating on shares of GE HealthCare Technologies in a research report on Saturday, September 27th. Zacks Research lowered shares of GE HealthCare Technologies from a “strong-buy” rating to a “hold” rating in a research report on Monday, September 29th. Wall Street Zen lowered shares of GE HealthCare Technologies from a “buy” rating to a “hold” rating in a research report on Saturday, September 20th. BTIG Research reaffirmed a “buy” rating on shares of GE HealthCare Technologies in a research report on Monday, July 14th. Finally, Morgan Stanley set a $74.00 target price on shares of GE HealthCare Technologies in a research report on Thursday, September 18th. Six analysts have rated the stock with a Buy rating and five have given a Hold rating to the company’s stock. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average price target of $85.78.

GE HealthCare Technologies Stock Performance

Shares of GEHC stock opened at $71.01 on Friday. The firm has a market cap of $32.42 billion, a price-to-earnings ratio of 14.55, a PEG ratio of 2.84 and a beta of 1.13. The company’s 50 day moving average is $74.31 and its 200 day moving average is $72.34. The company has a quick ratio of 0.93, a current ratio of 1.16 and a debt-to-equity ratio of 0.85. GE HealthCare Technologies Inc. has a 52-week low of $57.65 and a 52-week high of $94.80.

GE HealthCare Technologies (NASDAQ:GEHC) last issued its quarterly earnings data on Wednesday, July 30th. The company reported $1.06 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.91 by $0.15. The company had revenue of $5 billion for the quarter, compared to analyst estimates of $4.96 billion. GE HealthCare Technologies had a net margin of 11.22% and a return on equity of 23.93%. GE HealthCare Technologies’s revenue was up 3.5% compared to the same quarter last year. During the same period last year, the company posted $1.00 earnings per share. GE HealthCare Technologies has set its FY 2025 guidance at 4.430-4.630 EPS. On average, sell-side analysts anticipate that GE HealthCare Technologies Inc. will post 4.68 EPS for the current fiscal year.

GE HealthCare Technologies Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, November 14th. Investors of record on Friday, October 24th will be issued a dividend of $0.035 per share. This represents a $0.14 annualized dividend and a yield of 0.2%. The ex-dividend date of this dividend is Friday, October 24th. GE HealthCare Technologies’s dividend payout ratio (DPR) is presently 2.87%.

GE HealthCare Technologies Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.